Share via Email

* Email To: (Separate multiple addresses with a semicolon)
* Your Name:
* Email From: (Your IP Address is 3.142.197.212)
* Email Subject: (personalize your message)


Email Content:

Merck Reports Q4 and Fiscal 2019 Financials

 02/07/2020

In a press release dated 5th February Merck & Co. Inc. (MRK) reported results for Q4 and FY 2019 ending December 31st 2019. For the quarter the company earned $2.36 billion on sales of $11.87 billion with an EPS of $0.92. For Q4 of FY 2018 comparative figures were $1.83 billion earned on sales of $10.99 billion with an EPS of $0.69.

For FY 2019 earnings were $9.84 billion on sales of $46.89 billion with an EPS of $3.81 up 64 percent over FY 2018.

The Animal Health segment represented 9.5 percent of sales for the most recent quarter at $1.11 billion, up 8.3 percent from Q4 FY 2018. Livestock including poultry represented 69 percent of Animal Health revenue up from 66 percent in the corresponding quarter of 2018.